nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—Tamoxifen—breast cancer	0.304	1	CrCtD
Toremifene—ESR1—breast cancer	0.0629	0.366	CbGaD
Toremifene—CYP1A1—breast cancer	0.0503	0.292	CbGaD
Toremifene—ESR1—Fluoxymesterone—breast cancer	0.0427	0.202	CbGbCtD
Toremifene—ESR1—Fulvestrant—breast cancer	0.0397	0.188	CbGbCtD
Toremifene—Bedaquiline—Tamoxifen—breast cancer	0.0324	0.163	CrCrCtD
Toremifene—CYP3A4—breast cancer	0.0321	0.187	CbGaD
Toremifene—Clomifene—Tamoxifen—breast cancer	0.0295	0.148	CrCrCtD
Toremifene—Ospemifene—Tamoxifen—breast cancer	0.0295	0.148	CrCrCtD
Toremifene—ABCB1—breast cancer	0.0267	0.155	CbGaD
Toremifene—ESR1—Raloxifene—breast cancer	0.0236	0.112	CbGbCtD
Toremifene—Naftifine—Tamoxifen—breast cancer	0.0162	0.0815	CrCrCtD
Toremifene—ESR1—Tamoxifen—breast cancer	0.0156	0.0737	CbGbCtD
Toremifene—Loperamide—Tamoxifen—breast cancer	0.013	0.0654	CrCrCtD
Toremifene—Doxylamine—Tamoxifen—breast cancer	0.0113	0.0565	CrCrCtD
Toremifene—Dextropropoxyphene—Tamoxifen—breast cancer	0.0107	0.0537	CrCrCtD
Toremifene—Phenoxybenzamine—Tamoxifen—breast cancer	0.0107	0.0537	CrCrCtD
Toremifene—Bromodiphenhydramine—Tamoxifen—breast cancer	0.00952	0.0478	CrCrCtD
Toremifene—CYP1A2—Anastrozole—breast cancer	0.00915	0.0432	CbGbCtD
Toremifene—Clofedanol—Tamoxifen—breast cancer	0.00773	0.0388	CrCrCtD
Toremifene—Benzphetamine—Tamoxifen—breast cancer	0.00748	0.0376	CrCrCtD
Toremifene—Orphenadrine—Tamoxifen—breast cancer	0.00748	0.0376	CrCrCtD
Toremifene—Benzyl Benzoate—Tamoxifen—breast cancer	0.00693	0.0348	CrCrCtD
Toremifene—CYP1A1—Tamoxifen—breast cancer	0.00684	0.0323	CbGbCtD
Toremifene—Diphenhydramine—Tamoxifen—breast cancer	0.00664	0.0334	CrCrCtD
Toremifene—CYP3A4—Exemestane—breast cancer	0.00632	0.0299	CbGbCtD
Toremifene—CYP3A4—Letrozole—breast cancer	0.00538	0.0254	CbGbCtD
Toremifene—ABCB1—Lapatinib—breast cancer	0.00534	0.0252	CbGbCtD
Toremifene—CYP3A4—Anastrozole—breast cancer	0.00479	0.0227	CbGbCtD
Toremifene—CYP3A4—Fulvestrant—breast cancer	0.00408	0.0193	CbGbCtD
Toremifene—CYP3A4—Thiotepa—breast cancer	0.00363	0.0172	CbGbCtD
Toremifene—CYP3A4—Ixabepilone—breast cancer	0.00332	0.0157	CbGbCtD
Toremifene—CYP3A4—Lapatinib—breast cancer	0.0032	0.0151	CbGbCtD
Toremifene—CYP1A2—Tamoxifen—breast cancer	0.00306	0.0144	CbGbCtD
Toremifene—ABCB1—Vinorelbine—breast cancer	0.00296	0.014	CbGbCtD
Toremifene—ABCB1—Tamoxifen—breast cancer	0.00267	0.0126	CbGbCtD
Toremifene—ABCB1—Mitoxantrone—breast cancer	0.00261	0.0123	CbGbCtD
Toremifene—CYP3A4—Raloxifene—breast cancer	0.00242	0.0115	CbGbCtD
Toremifene—ABCB1—Gemcitabine—breast cancer	0.0023	0.0109	CbGbCtD
Toremifene—CYP1A2—Fluorouracil—breast cancer	0.00225	0.0106	CbGbCtD
Toremifene—ABCB1—Paclitaxel—breast cancer	0.00208	0.00983	CbGbCtD
Toremifene—ABCB1—Irinotecan—breast cancer	0.00205	0.0097	CbGbCtD
Toremifene—ABCB1—Vinblastine—breast cancer	0.00182	0.00862	CbGbCtD
Toremifene—CYP3A4—Vinorelbine—breast cancer	0.00177	0.00838	CbGbCtD
Toremifene—CYP3A4—Tamoxifen—breast cancer	0.0016	0.00757	CbGbCtD
Toremifene—CYP3A4—Mitoxantrone—breast cancer	0.00156	0.00738	CbGbCtD
Toremifene—ABCB1—Docetaxel—breast cancer	0.0015	0.00711	CbGbCtD
Toremifene—CYP3A4—Paclitaxel—breast cancer	0.00125	0.00589	CbGbCtD
Toremifene—CYP3A4—Irinotecan—breast cancer	0.00123	0.00581	CbGbCtD
Toremifene—ABCB1—Doxorubicin—breast cancer	0.00112	0.0053	CbGbCtD
Toremifene—CYP3A4—Vinblastine—breast cancer	0.00109	0.00517	CbGbCtD
Toremifene—ABCB1—Methotrexate—breast cancer	0.00109	0.00513	CbGbCtD
Toremifene—CYP3A4—Docetaxel—breast cancer	0.000901	0.00426	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—breast cancer	0.000672	0.00317	CbGbCtD
Toremifene—Tamoxifen—ESRRA—breast cancer	0.000219	0.162	CrCbGaD
Toremifene—ESR1—mammary gland—breast cancer	0.000195	0.08	CbGeAlD
Toremifene—Tamoxifen—SULT1A1—breast cancer	0.000166	0.123	CrCbGaD
Toremifene—ESR1—embryo—breast cancer	0.000133	0.0546	CbGeAlD
Toremifene—CYP1A2—nipple—breast cancer	0.000124	0.051	CbGeAlD
Toremifene—CYP1A1—nipple—breast cancer	0.000123	0.0503	CbGeAlD
Toremifene—ESR1—epithelium—breast cancer	0.000109	0.0445	CbGeAlD
Toremifene—ESR1—endometrium—breast cancer	9.73e-05	0.0399	CbGeAlD
Toremifene—Bedaquiline—CYP3A4—breast cancer	9e-05	0.0667	CrCbGaD
Toremifene—ESR1—uterus—breast cancer	8.97e-05	0.0368	CbGeAlD
Toremifene—Ospemifene—ESR1—breast cancer	8.84e-05	0.0655	CrCbGaD
Toremifene—ESR1—pituitary gland—breast cancer	8.8e-05	0.0361	CbGeAlD
Toremifene—ESR1—adipose tissue—breast cancer	8.77e-05	0.036	CbGeAlD
Toremifene—CYP1A1—epithelium—breast cancer	8.25e-05	0.0339	CbGeAlD
Toremifene—ESR1—female reproductive system—breast cancer	8.06e-05	0.0331	CbGeAlD
Toremifene—ESR1—adrenal gland—breast cancer	7.87e-05	0.0323	CbGeAlD
Toremifene—CYP1A1—skin of body—breast cancer	7.85e-05	0.0322	CbGeAlD
Toremifene—ESR1—female gonad—breast cancer	7.33e-05	0.0301	CbGeAlD
Toremifene—ESR1—endocrine gland—breast cancer	6.82e-05	0.028	CbGeAlD
Toremifene—CYP1A1—uterus—breast cancer	6.82e-05	0.028	CbGeAlD
Toremifene—Clomifene—CYP19A1—breast cancer	6.77e-05	0.0502	CrCbGaD
Toremifene—CYP1A1—adipose tissue—breast cancer	6.67e-05	0.0274	CbGeAlD
Toremifene—Clomifene—ESR1—breast cancer	6.23e-05	0.0462	CrCbGaD
Toremifene—CYP1A1—female reproductive system—breast cancer	6.13e-05	0.0252	CbGeAlD
Toremifene—CYP1A1—female gonad—breast cancer	5.58e-05	0.0229	CbGeAlD
Toremifene—Orphenadrine—SCN10A—breast cancer	5.41e-05	0.0401	CrCbGaD
Toremifene—CYP1A2—endocrine gland—breast cancer	5.26e-05	0.0216	CbGeAlD
Toremifene—ABCB1—embryo—breast cancer	5.25e-05	0.0216	CbGeAlD
Toremifene—CYP1A1—endocrine gland—breast cancer	5.19e-05	0.0213	CbGeAlD
Toremifene—Clomifene—CYP1A1—breast cancer	4.98e-05	0.0369	CrCbGaD
Toremifene—ESR1—lymph node—breast cancer	4.72e-05	0.0194	CbGeAlD
Toremifene—Tamoxifen—ESR2—breast cancer	4.67e-05	0.0346	CrCbGaD
Toremifene—Ospemifene—CYP3A4—breast cancer	4.51e-05	0.0334	CrCbGaD
Toremifene—CYP3A4—female reproductive system—breast cancer	4.5e-05	0.0185	CbGeAlD
Toremifene—ABCB1—epithelium—breast cancer	4.29e-05	0.0176	CbGeAlD
Toremifene—Tamoxifen—CYP1B1—breast cancer	4.26e-05	0.0316	CrCbGaD
Toremifene—ABCB1—endometrium—breast cancer	3.84e-05	0.0158	CbGeAlD
Toremifene—CYP3A4—endocrine gland—breast cancer	3.81e-05	0.0156	CbGeAlD
Toremifene—CYP1A1—lymph node—breast cancer	3.59e-05	0.0147	CbGeAlD
Toremifene—ABCB1—uterus—breast cancer	3.54e-05	0.0145	CbGeAlD
Toremifene—ABCB1—pituitary gland—breast cancer	3.48e-05	0.0143	CbGeAlD
Toremifene—ABCB1—adipose tissue—breast cancer	3.46e-05	0.0142	CbGeAlD
Toremifene—ABCB1—female reproductive system—breast cancer	3.18e-05	0.0131	CbGeAlD
Toremifene—Clomifene—CYP3A4—breast cancer	3.18e-05	0.0236	CrCbGaD
Toremifene—Tamoxifen—CYP19A1—breast cancer	3.13e-05	0.0232	CrCbGaD
Toremifene—ABCB1—adrenal gland—breast cancer	3.11e-05	0.0128	CbGeAlD
Toremifene—ABCB1—bone marrow—breast cancer	3.01e-05	0.0123	CbGeAlD
Toremifene—Tamoxifen—ABCG2—breast cancer	2.94e-05	0.0218	CrCbGaD
Toremifene—ABCB1—female gonad—breast cancer	2.9e-05	0.0119	CbGeAlD
Toremifene—Tamoxifen—ESR1—breast cancer	2.88e-05	0.0213	CrCbGaD
Toremifene—ABCB1—endocrine gland—breast cancer	2.69e-05	0.0111	CbGeAlD
Toremifene—Clomifene—ABCB1—breast cancer	2.65e-05	0.0196	CrCbGaD
Toremifene—Diphenhydramine—PTGS1—breast cancer	2.58e-05	0.0192	CrCbGaD
Toremifene—Dextropropoxyphene—CYP2D6—breast cancer	2.5e-05	0.0186	CrCbGaD
Toremifene—Loperamide—CYP2D6—breast cancer	2.38e-05	0.0177	CrCbGaD
Toremifene—Tamoxifen—CYP1A1—breast cancer	2.3e-05	0.0171	CrCbGaD
Toremifene—Dextropropoxyphene—CYP3A4—breast cancer	2.15e-05	0.0159	CrCbGaD
Toremifene—Arrhythmia—Capecitabine—breast cancer	2.09e-05	0.000282	CcSEcCtD
Toremifene—Gastrointestinal disorder—Gemcitabine—breast cancer	2.09e-05	0.000281	CcSEcCtD
Toremifene—Fatigue—Gemcitabine—breast cancer	2.09e-05	0.000281	CcSEcCtD
Toremifene—Constipation—Gemcitabine—breast cancer	2.07e-05	0.000279	CcSEcCtD
Toremifene—Pain—Gemcitabine—breast cancer	2.07e-05	0.000279	CcSEcCtD
Toremifene—Decreased appetite—Fluorouracil—breast cancer	2.07e-05	0.000279	CcSEcCtD
Toremifene—Alopecia—Capecitabine—breast cancer	2.07e-05	0.000279	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—breast cancer	2.07e-05	0.000278	CcSEcCtD
Toremifene—Asthenia—Thiotepa—breast cancer	2.06e-05	0.000278	CcSEcCtD
Toremifene—Gastrointestinal disorder—Fluorouracil—breast cancer	2.05e-05	0.000277	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—breast cancer	2.05e-05	0.000276	CcSEcCtD
Toremifene—Mental disorder—Capecitabine—breast cancer	2.05e-05	0.000276	CcSEcCtD
Toremifene—Nausea—Melphalan—breast cancer	2.05e-05	0.000276	CcSEcCtD
Toremifene—Loperamide—CYP3A4—breast cancer	2.05e-05	0.0152	CrCbGaD
Toremifene—Malnutrition—Capecitabine—breast cancer	2.04e-05	0.000274	CcSEcCtD
Toremifene—Back pain—Docetaxel—breast cancer	2.04e-05	0.000274	CcSEcCtD
Toremifene—Pruritus—Thiotepa—breast cancer	2.04e-05	0.000274	CcSEcCtD
Toremifene—Pain—Fluorouracil—breast cancer	2.03e-05	0.000274	CcSEcCtD
Toremifene—Oedema—Paclitaxel—breast cancer	2.03e-05	0.000273	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—breast cancer	2.01e-05	0.000271	CcSEcCtD
Toremifene—Nausea—Goserelin—breast cancer	2e-05	0.000269	CcSEcCtD
Toremifene—Dizziness—Vinorelbine—breast cancer	1.99e-05	0.000268	CcSEcCtD
Toremifene—Nervous system disorder—Paclitaxel—breast cancer	1.99e-05	0.000268	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—breast cancer	1.98e-05	0.000267	CcSEcCtD
Toremifene—Thrombocytopenia—Paclitaxel—breast cancer	1.98e-05	0.000267	CcSEcCtD
Toremifene—Back pain—Capecitabine—breast cancer	1.97e-05	0.000265	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—breast cancer	1.97e-05	0.000265	CcSEcCtD
Toremifene—Skin disorder—Paclitaxel—breast cancer	1.97e-05	0.000265	CcSEcCtD
Toremifene—Hyperhidrosis—Paclitaxel—breast cancer	1.96e-05	0.000264	CcSEcCtD
Toremifene—Anorexia—Paclitaxel—breast cancer	1.93e-05	0.00026	CcSEcCtD
Toremifene—Vision blurred—Capecitabine—breast cancer	1.92e-05	0.000259	CcSEcCtD
Toremifene—Vomiting—Vinorelbine—breast cancer	1.92e-05	0.000258	CcSEcCtD
Toremifene—Tremor—Capecitabine—breast cancer	1.91e-05	0.000257	CcSEcCtD
Toremifene—Dizziness—Thiotepa—breast cancer	1.9e-05	0.000256	CcSEcCtD
Toremifene—Rash—Vinorelbine—breast cancer	1.9e-05	0.000256	CcSEcCtD
Toremifene—Dermatitis—Vinorelbine—breast cancer	1.9e-05	0.000256	CcSEcCtD
Toremifene—Headache—Vinorelbine—breast cancer	1.89e-05	0.000254	CcSEcCtD
Toremifene—Leukopenia—Docetaxel—breast cancer	1.88e-05	0.000254	CcSEcCtD
Toremifene—Benzphetamine—CYP3A4—breast cancer	1.88e-05	0.014	CrCbGaD
Toremifene—ABCB1—lymph node—breast cancer	1.86e-05	0.00765	CbGeAlD
Toremifene—Sweating—Methotrexate—breast cancer	1.86e-05	0.000251	CcSEcCtD
Toremifene—Weight increased—Epirubicin—breast cancer	1.85e-05	0.00025	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—breast cancer	1.84e-05	0.000247	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—breast cancer	1.84e-05	0.000247	CcSEcCtD
Toremifene—Insomnia—Paclitaxel—breast cancer	1.83e-05	0.000247	CcSEcCtD
Toremifene—Vertigo—Capecitabine—breast cancer	1.83e-05	0.000247	CcSEcCtD
Toremifene—Vomiting—Thiotepa—breast cancer	1.83e-05	0.000246	CcSEcCtD
Toremifene—Leukopenia—Capecitabine—breast cancer	1.82e-05	0.000246	CcSEcCtD
Toremifene—Rash—Thiotepa—breast cancer	1.81e-05	0.000244	CcSEcCtD
Toremifene—Dermatitis—Thiotepa—breast cancer	1.81e-05	0.000244	CcSEcCtD
Toremifene—Dyspnoea—Paclitaxel—breast cancer	1.81e-05	0.000243	CcSEcCtD
Toremifene—Headache—Thiotepa—breast cancer	1.8e-05	0.000243	CcSEcCtD
Toremifene—Phenoxybenzamine—CYP3A4—breast cancer	1.8e-05	0.0133	CrCbGaD
Toremifene—Chest pain—Docetaxel—breast cancer	1.79e-05	0.000241	CcSEcCtD
Toremifene—Nausea—Vinorelbine—breast cancer	1.79e-05	0.000241	CcSEcCtD
Toremifene—Asthenia—Mitoxantrone—breast cancer	1.78e-05	0.00024	CcSEcCtD
Toremifene—Asthenia—Irinotecan—breast cancer	1.78e-05	0.00024	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—breast cancer	1.78e-05	0.00024	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	1.78e-05	0.00024	CcSEcCtD
Toremifene—Jaundice—Epirubicin—breast cancer	1.77e-05	0.000238	CcSEcCtD
Toremifene—Decreased appetite—Paclitaxel—breast cancer	1.76e-05	0.000237	CcSEcCtD
Toremifene—Diphenhydramine—CYP2D6—breast cancer	1.76e-05	0.013	CrCbGaD
Toremifene—Gastrointestinal disorder—Paclitaxel—breast cancer	1.75e-05	0.000236	CcSEcCtD
Toremifene—Fatigue—Paclitaxel—breast cancer	1.75e-05	0.000235	CcSEcCtD
Toremifene—Sweating—Epirubicin—breast cancer	1.74e-05	0.000235	CcSEcCtD
Toremifene—Asthenia—Gemcitabine—breast cancer	1.74e-05	0.000234	CcSEcCtD
Toremifene—Chest pain—Capecitabine—breast cancer	1.73e-05	0.000234	CcSEcCtD
Toremifene—Pain—Paclitaxel—breast cancer	1.73e-05	0.000233	CcSEcCtD
Toremifene—Constipation—Paclitaxel—breast cancer	1.73e-05	0.000233	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	1.72e-05	0.000232	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—breast cancer	1.72e-05	0.000231	CcSEcCtD
Toremifene—Oedema—Docetaxel—breast cancer	1.72e-05	0.000231	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—breast cancer	1.72e-05	0.000231	CcSEcCtD
Toremifene—Pruritus—Gemcitabine—breast cancer	1.71e-05	0.000231	CcSEcCtD
Toremifene—Tamoxifen—CYP2D6—breast cancer	1.71e-05	0.0127	CrCbGaD
Toremifene—Nausea—Thiotepa—breast cancer	1.71e-05	0.00023	CcSEcCtD
Toremifene—Loperamide—ABCB1—breast cancer	1.7e-05	0.0126	CrCbGaD
Toremifene—Nervous system disorder—Docetaxel—breast cancer	1.68e-05	0.000227	CcSEcCtD
Toremifene—Pruritus—Fluorouracil—breast cancer	1.68e-05	0.000227	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—breast cancer	1.68e-05	0.000226	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—breast cancer	1.68e-05	0.000226	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—breast cancer	1.67e-05	0.000225	CcSEcCtD
Toremifene—Oedema—Capecitabine—breast cancer	1.66e-05	0.000224	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—breast cancer	1.65e-05	0.000222	CcSEcCtD
Toremifene—Dizziness—Irinotecan—breast cancer	1.64e-05	0.000221	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—breast cancer	1.64e-05	0.000221	CcSEcCtD
Toremifene—Anorexia—Docetaxel—breast cancer	1.64e-05	0.00022	CcSEcCtD
Toremifene—Nervous system disorder—Capecitabine—breast cancer	1.63e-05	0.00022	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—breast cancer	1.63e-05	0.000219	CcSEcCtD
Toremifene—Thrombocytopenia—Capecitabine—breast cancer	1.63e-05	0.000219	CcSEcCtD
Toremifene—Skin disorder—Capecitabine—breast cancer	1.62e-05	0.000218	CcSEcCtD
Toremifene—Sweating—Doxorubicin—breast cancer	1.61e-05	0.000217	CcSEcCtD
Toremifene—Hyperhidrosis—Capecitabine—breast cancer	1.61e-05	0.000216	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—breast cancer	1.59e-05	0.000214	CcSEcCtD
Toremifene—Anorexia—Capecitabine—breast cancer	1.59e-05	0.000213	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—breast cancer	1.58e-05	0.000213	CcSEcCtD
Toremifene—Vomiting—Mitoxantrone—breast cancer	1.58e-05	0.000213	CcSEcCtD
Toremifene—Vomiting—Irinotecan—breast cancer	1.58e-05	0.000213	CcSEcCtD
Toremifene—Dizziness—Fluorouracil—breast cancer	1.57e-05	0.000212	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—breast cancer	1.57e-05	0.000212	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—breast cancer	1.57e-05	0.000211	CcSEcCtD
Toremifene—Rash—Irinotecan—breast cancer	1.57e-05	0.000211	CcSEcCtD
Toremifene—Rash—Mitoxantrone—breast cancer	1.57e-05	0.000211	CcSEcCtD
Toremifene—Dermatitis—Mitoxantrone—breast cancer	1.57e-05	0.000211	CcSEcCtD
Toremifene—Dermatitis—Irinotecan—breast cancer	1.57e-05	0.000211	CcSEcCtD
Toremifene—Chills—Methotrexate—breast cancer	1.56e-05	0.000211	CcSEcCtD
Toremifene—Headache—Mitoxantrone—breast cancer	1.56e-05	0.00021	CcSEcCtD
Toremifene—Headache—Irinotecan—breast cancer	1.56e-05	0.00021	CcSEcCtD
Toremifene—Insomnia—Docetaxel—breast cancer	1.55e-05	0.000209	CcSEcCtD
Toremifene—Alopecia—Methotrexate—breast cancer	1.54e-05	0.000207	CcSEcCtD
Toremifene—Vomiting—Gemcitabine—breast cancer	1.54e-05	0.000207	CcSEcCtD
Toremifene—Dyspnoea—Docetaxel—breast cancer	1.53e-05	0.000206	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—breast cancer	1.53e-05	0.000206	CcSEcCtD
Toremifene—Rash—Gemcitabine—breast cancer	1.53e-05	0.000206	CcSEcCtD
Toremifene—Dermatitis—Gemcitabine—breast cancer	1.52e-05	0.000205	CcSEcCtD
Toremifene—Eye disorder—Epirubicin—breast cancer	1.52e-05	0.000205	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—breast cancer	1.52e-05	0.000204	CcSEcCtD
Toremifene—Headache—Gemcitabine—breast cancer	1.52e-05	0.000204	CcSEcCtD
Toremifene—Vomiting—Fluorouracil—breast cancer	1.51e-05	0.000204	CcSEcCtD
Toremifene—Insomnia—Capecitabine—breast cancer	1.5e-05	0.000203	CcSEcCtD
Toremifene—Rash—Fluorouracil—breast cancer	1.5e-05	0.000202	CcSEcCtD
Toremifene—Dermatitis—Fluorouracil—breast cancer	1.5e-05	0.000202	CcSEcCtD
Toremifene—Decreased appetite—Docetaxel—breast cancer	1.49e-05	0.000201	CcSEcCtD
Toremifene—Headache—Fluorouracil—breast cancer	1.49e-05	0.000201	CcSEcCtD
Toremifene—Gastrointestinal disorder—Docetaxel—breast cancer	1.48e-05	0.0002	CcSEcCtD
Toremifene—Dyspnoea—Capecitabine—breast cancer	1.48e-05	0.0002	CcSEcCtD
Toremifene—Fatigue—Docetaxel—breast cancer	1.48e-05	0.000199	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—breast cancer	1.48e-05	0.000199	CcSEcCtD
Toremifene—Nausea—Mitoxantrone—breast cancer	1.48e-05	0.000199	CcSEcCtD
Toremifene—Nausea—Irinotecan—breast cancer	1.48e-05	0.000199	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—breast cancer	1.47e-05	0.000198	CcSEcCtD
Toremifene—Constipation—Docetaxel—breast cancer	1.47e-05	0.000198	CcSEcCtD
Toremifene—Pain—Docetaxel—breast cancer	1.47e-05	0.000198	CcSEcCtD
Toremifene—Tamoxifen—CYP3A4—breast cancer	1.47e-05	0.0109	CrCbGaD
Toremifene—Back pain—Methotrexate—breast cancer	1.47e-05	0.000198	CcSEcCtD
Toremifene—Chills—Epirubicin—breast cancer	1.46e-05	0.000197	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—breast cancer	1.46e-05	0.000196	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—breast cancer	1.45e-05	0.000196	CcSEcCtD
Toremifene—Asthenia—Paclitaxel—breast cancer	1.45e-05	0.000196	CcSEcCtD
Toremifene—Decreased appetite—Capecitabine—breast cancer	1.45e-05	0.000195	CcSEcCtD
Toremifene—Alopecia—Epirubicin—breast cancer	1.44e-05	0.000194	CcSEcCtD
Toremifene—Nausea—Gemcitabine—breast cancer	1.44e-05	0.000194	CcSEcCtD
Toremifene—Gastrointestinal disorder—Capecitabine—breast cancer	1.44e-05	0.000193	CcSEcCtD
Toremifene—Fatigue—Capecitabine—breast cancer	1.43e-05	0.000193	CcSEcCtD
Toremifene—Pruritus—Paclitaxel—breast cancer	1.43e-05	0.000193	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—breast cancer	1.43e-05	0.000193	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—breast cancer	1.43e-05	0.000192	CcSEcCtD
Toremifene—Orphenadrine—CYP3A4—breast cancer	1.43e-05	0.0106	CrCbGaD
Toremifene—Pain—Capecitabine—breast cancer	1.42e-05	0.000192	CcSEcCtD
Toremifene—Constipation—Capecitabine—breast cancer	1.42e-05	0.000192	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—breast cancer	1.42e-05	0.000191	CcSEcCtD
Toremifene—Nausea—Fluorouracil—breast cancer	1.41e-05	0.00019	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—breast cancer	1.41e-05	0.00019	CcSEcCtD
Toremifene—Back pain—Epirubicin—breast cancer	1.37e-05	0.000185	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—breast cancer	1.37e-05	0.000184	CcSEcCtD
Toremifene—Vertigo—Methotrexate—breast cancer	1.36e-05	0.000184	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—breast cancer	1.36e-05	0.000183	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—breast cancer	1.36e-05	0.000183	CcSEcCtD
Toremifene—Chills—Doxorubicin—breast cancer	1.35e-05	0.000182	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—breast cancer	1.35e-05	0.000182	CcSEcCtD
Toremifene—Dizziness—Paclitaxel—breast cancer	1.34e-05	0.00018	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—breast cancer	1.34e-05	0.00018	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—breast cancer	1.33e-05	0.00018	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—breast cancer	1.32e-05	0.000178	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—breast cancer	1.31e-05	0.000177	CcSEcCtD
Toremifene—Chest pain—Methotrexate—breast cancer	1.29e-05	0.000174	CcSEcCtD
Toremifene—Vomiting—Paclitaxel—breast cancer	1.29e-05	0.000174	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.28e-05	0.000173	CcSEcCtD
Toremifene—Rash—Paclitaxel—breast cancer	1.28e-05	0.000172	CcSEcCtD
Toremifene—Dermatitis—Paclitaxel—breast cancer	1.28e-05	0.000172	CcSEcCtD
Toremifene—Vertigo—Epirubicin—breast cancer	1.28e-05	0.000172	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—breast cancer	1.27e-05	0.000171	CcSEcCtD
Toremifene—Back pain—Doxorubicin—breast cancer	1.27e-05	0.000171	CcSEcCtD
Toremifene—Headache—Paclitaxel—breast cancer	1.27e-05	0.000171	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—breast cancer	1.24e-05	0.000167	CcSEcCtD
Toremifene—Asthenia—Docetaxel—breast cancer	1.23e-05	0.000166	CcSEcCtD
Toremifene—Tamoxifen—ABCB1—breast cancer	1.22e-05	0.00906	CrCbGaD
Toremifene—Pruritus—Docetaxel—breast cancer	1.22e-05	0.000164	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—breast cancer	1.21e-05	0.000163	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—breast cancer	1.21e-05	0.000163	CcSEcCtD
Toremifene—Chest pain—Epirubicin—breast cancer	1.21e-05	0.000163	CcSEcCtD
Toremifene—Nausea—Paclitaxel—breast cancer	1.2e-05	0.000162	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—breast cancer	1.2e-05	0.000162	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.2e-05	0.000162	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—breast cancer	1.2e-05	0.000161	CcSEcCtD
Toremifene—Asthenia—Capecitabine—breast cancer	1.19e-05	0.000161	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—breast cancer	1.18e-05	0.000159	CcSEcCtD
Toremifene—Anorexia—Methotrexate—breast cancer	1.18e-05	0.000159	CcSEcCtD
Toremifene—Pruritus—Capecitabine—breast cancer	1.18e-05	0.000158	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—breast cancer	1.18e-05	0.000158	CcSEcCtD
Toremifene—Oedema—Epirubicin—breast cancer	1.16e-05	0.000156	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—breast cancer	1.14e-05	0.000153	CcSEcCtD
Toremifene—Dizziness—Docetaxel—breast cancer	1.14e-05	0.000153	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—breast cancer	1.13e-05	0.000153	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—breast cancer	1.13e-05	0.000152	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—breast cancer	1.12e-05	0.000151	CcSEcCtD
Toremifene—Insomnia—Methotrexate—breast cancer	1.12e-05	0.000151	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—breast cancer	1.12e-05	0.000151	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.11e-05	0.00015	CcSEcCtD
Toremifene—Anorexia—Epirubicin—breast cancer	1.1e-05	0.000149	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—breast cancer	1.1e-05	0.000149	CcSEcCtD
Toremifene—Dizziness—Capecitabine—breast cancer	1.1e-05	0.000148	CcSEcCtD
Toremifene—Vomiting—Docetaxel—breast cancer	1.09e-05	0.000147	CcSEcCtD
Toremifene—Rash—Docetaxel—breast cancer	1.08e-05	0.000146	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—breast cancer	1.08e-05	0.000146	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—breast cancer	1.08e-05	0.000145	CcSEcCtD
Toremifene—Headache—Docetaxel—breast cancer	1.08e-05	0.000145	CcSEcCtD
Toremifene—Oedema—Doxorubicin—breast cancer	1.07e-05	0.000144	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—breast cancer	1.07e-05	0.000144	CcSEcCtD
Toremifene—Fatigue—Methotrexate—breast cancer	1.07e-05	0.000144	CcSEcCtD
Toremifene—Pain—Methotrexate—breast cancer	1.06e-05	0.000143	CcSEcCtD
Toremifene—Vomiting—Capecitabine—breast cancer	1.06e-05	0.000142	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—breast cancer	1.05e-05	0.000142	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—breast cancer	1.05e-05	0.000141	CcSEcCtD
Toremifene—Rash—Capecitabine—breast cancer	1.05e-05	0.000141	CcSEcCtD
Toremifene—Insomnia—Epirubicin—breast cancer	1.05e-05	0.000141	CcSEcCtD
Toremifene—Dermatitis—Capecitabine—breast cancer	1.05e-05	0.000141	CcSEcCtD
Toremifene—Headache—Capecitabine—breast cancer	1.04e-05	0.00014	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—breast cancer	1.04e-05	0.00014	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—breast cancer	1.04e-05	0.00014	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—breast cancer	1.03e-05	0.000139	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—breast cancer	1.02e-05	0.000138	CcSEcCtD
Toremifene—Nausea—Docetaxel—breast cancer	1.02e-05	0.000137	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—breast cancer	1.01e-05	0.000136	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—breast cancer	1e-05	0.000135	CcSEcCtD
Toremifene—Fatigue—Epirubicin—breast cancer	9.99e-06	0.000135	CcSEcCtD
Toremifene—Constipation—Epirubicin—breast cancer	9.91e-06	0.000133	CcSEcCtD
Toremifene—Pain—Epirubicin—breast cancer	9.91e-06	0.000133	CcSEcCtD
Toremifene—Nausea—Capecitabine—breast cancer	9.88e-06	0.000133	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—breast cancer	9.69e-06	0.000131	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—breast cancer	9.56e-06	0.000129	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—breast cancer	9.32e-06	0.000125	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—breast cancer	9.25e-06	0.000125	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—breast cancer	9.24e-06	0.000124	CcSEcCtD
Toremifene—Constipation—Doxorubicin—breast cancer	9.17e-06	0.000123	CcSEcCtD
Toremifene—Pain—Doxorubicin—breast cancer	9.17e-06	0.000123	CcSEcCtD
Toremifene—Asthenia—Methotrexate—breast cancer	8.88e-06	0.00012	CcSEcCtD
Toremifene—Pruritus—Methotrexate—breast cancer	8.76e-06	0.000118	CcSEcCtD
Toremifene—Asthenia—Epirubicin—breast cancer	8.31e-06	0.000112	CcSEcCtD
Toremifene—Pruritus—Epirubicin—breast cancer	8.2e-06	0.00011	CcSEcCtD
Toremifene—Dizziness—Methotrexate—breast cancer	8.19e-06	0.00011	CcSEcCtD
Toremifene—Vomiting—Methotrexate—breast cancer	7.87e-06	0.000106	CcSEcCtD
Toremifene—Rash—Methotrexate—breast cancer	7.8e-06	0.000105	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—breast cancer	7.8e-06	0.000105	CcSEcCtD
Toremifene—Headache—Methotrexate—breast cancer	7.75e-06	0.000104	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—breast cancer	7.69e-06	0.000104	CcSEcCtD
Toremifene—Dizziness—Epirubicin—breast cancer	7.66e-06	0.000103	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—breast cancer	7.58e-06	0.000102	CcSEcCtD
Toremifene—Vomiting—Epirubicin—breast cancer	7.37e-06	9.92e-05	CcSEcCtD
Toremifene—Nausea—Methotrexate—breast cancer	7.35e-06	9.9e-05	CcSEcCtD
Toremifene—Rash—Epirubicin—breast cancer	7.3e-06	9.84e-05	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—breast cancer	7.3e-06	9.83e-05	CcSEcCtD
Toremifene—Headache—Epirubicin—breast cancer	7.26e-06	9.77e-05	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—breast cancer	7.09e-06	9.55e-05	CcSEcCtD
Toremifene—Nausea—Epirubicin—breast cancer	6.88e-06	9.27e-05	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—breast cancer	6.82e-06	9.18e-05	CcSEcCtD
Toremifene—Rash—Doxorubicin—breast cancer	6.76e-06	9.1e-05	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—breast cancer	6.75e-06	9.09e-05	CcSEcCtD
Toremifene—Headache—Doxorubicin—breast cancer	6.71e-06	9.04e-05	CcSEcCtD
Toremifene—Nausea—Doxorubicin—breast cancer	6.37e-06	8.57e-05	CcSEcCtD
Toremifene—CYP3A4—Metabolism—BRIP1—breast cancer	2.12e-06	6.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPSE—breast cancer	2.12e-06	6.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—H2AFX—breast cancer	2.11e-06	6.03e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HSP90AA1—breast cancer	2.11e-06	6.02e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F1—breast cancer	2.1e-06	5.99e-05	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.09e-06	5.97e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOA1—breast cancer	2.05e-06	5.85e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP17A1—breast cancer	2.04e-06	5.82e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—STK11—breast cancer	2.02e-06	5.77e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP19A1—breast cancer	2.02e-06	5.77e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS1—breast cancer	2.02e-06	5.76e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO1—breast cancer	2.02e-06	5.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—breast cancer	2.01e-06	5.76e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMMR—breast cancer	2.01e-06	5.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA3—breast cancer	2.01e-06	5.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCC1—breast cancer	2.01e-06	5.75e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2e-06	5.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB3—breast cancer	1.99e-06	5.69e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR2—breast cancer	1.99e-06	5.69e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2D6—breast cancer	1.98e-06	5.65e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.95e-06	5.57e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DPYD—breast cancer	1.94e-06	5.55e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MED12—breast cancer	1.94e-06	5.55e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOA2—breast cancer	1.94e-06	5.55e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDOA—breast cancer	1.91e-06	5.47e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—breast cancer	1.91e-06	5.46e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.89e-06	5.42e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.89e-06	5.39e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FASN—breast cancer	1.88e-06	5.38e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—COMT—breast cancer	1.88e-06	5.36e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—breast cancer	1.87e-06	5.36e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—breast cancer	1.87e-06	5.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA3—breast cancer	1.86e-06	5.31e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR1—breast cancer	1.85e-06	5.3e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A5—breast cancer	1.85e-06	5.29e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A2—breast cancer	1.84e-06	5.27e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—breast cancer	1.84e-06	5.27e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA4—breast cancer	1.84e-06	5.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA9—breast cancer	1.84e-06	5.26e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ITPR1—breast cancer	1.84e-06	5.25e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—breast cancer	1.83e-06	5.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.82e-06	5.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CPT1A—breast cancer	1.81e-06	5.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTR—breast cancer	1.81e-06	5.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCG2—breast cancer	1.81e-06	5.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA2—breast cancer	1.79e-06	5.12e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX2—breast cancer	1.79e-06	5.12e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NQO1—breast cancer	1.79e-06	5.11e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A1—breast cancer	1.79e-06	5.11e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—breast cancer	1.78e-06	5.1e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HPGDS—breast cancer	1.77e-06	5.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX4—breast cancer	1.77e-06	5.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SULT1A1—breast cancer	1.77e-06	5.06e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—breast cancer	1.77e-06	5.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—breast cancer	1.77e-06	5.05e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HBA1—breast cancer	1.76e-06	5.03e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—breast cancer	1.75e-06	4.99e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP3A4—breast cancer	1.74e-06	4.99e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMS—breast cancer	1.74e-06	4.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH1—breast cancer	1.73e-06	4.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA1—breast cancer	1.73e-06	4.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACHE—breast cancer	1.72e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—breast cancer	1.72e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLA2G4A—breast cancer	1.72e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOR1—breast cancer	1.72e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—breast cancer	1.72e-06	4.91e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1B1—breast cancer	1.71e-06	4.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAT2—breast cancer	1.71e-06	4.89e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.71e-06	4.88e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HSP90AA1—breast cancer	1.68e-06	4.81e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—breast cancer	1.68e-06	4.8e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKBIA—breast cancer	1.66e-06	4.75e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—breast cancer	1.65e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—breast cancer	1.64e-06	4.7e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOA1—breast cancer	1.64e-06	4.68e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP17A1—breast cancer	1.63e-06	4.65e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ERCC2—breast cancer	1.61e-06	4.61e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—STK11—breast cancer	1.61e-06	4.61e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP19A1—breast cancer	1.61e-06	4.61e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO1—breast cancer	1.61e-06	4.6e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS1—breast cancer	1.61e-06	4.6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—breast cancer	1.61e-06	4.6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—breast cancer	1.61e-06	4.6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—breast cancer	1.61e-06	4.6e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.6e-06	4.59e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGF—breast cancer	1.59e-06	4.55e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.58e-06	4.53e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2D6—breast cancer	1.58e-06	4.51e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA2—breast cancer	1.55e-06	4.43e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—breast cancer	1.52e-06	4.34e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—breast cancer	1.51e-06	4.32e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FASN—breast cancer	1.5e-06	4.3e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MED12—breast cancer	1.5e-06	4.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DPYD—breast cancer	1.5e-06	4.29e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—COMT—breast cancer	1.5e-06	4.28e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—breast cancer	1.5e-06	4.28e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—breast cancer	1.49e-06	4.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A5—breast cancer	1.48e-06	4.23e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDOA—breast cancer	1.48e-06	4.22e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—breast cancer	1.47e-06	4.21e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT2—breast cancer	1.47e-06	4.21e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—breast cancer	1.47e-06	4.21e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ITPR1—breast cancer	1.47e-06	4.2e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA3—breast cancer	1.43e-06	4.1e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A1—breast cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NQO1—breast cancer	1.43e-06	4.08e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A2—breast cancer	1.42e-06	4.07e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—breast cancer	1.41e-06	4.04e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—breast cancer	1.4e-06	4e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—breast cancer	1.4e-06	4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—breast cancer	1.4e-06	4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.4e-06	4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTR—breast cancer	1.39e-06	3.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CPT1A—breast cancer	1.39e-06	3.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG2—breast cancer	1.39e-06	3.98e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP3A4—breast cancer	1.39e-06	3.98e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMS—breast cancer	1.39e-06	3.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.39e-06	3.96e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOR1—breast cancer	1.37e-06	3.92e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—breast cancer	1.37e-06	3.92e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLA2G4A—breast cancer	1.37e-06	3.92e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1B1—breast cancer	1.37e-06	3.91e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPGDS—breast cancer	1.37e-06	3.91e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—breast cancer	1.36e-06	3.89e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HBA1—breast cancer	1.36e-06	3.88e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.34e-06	3.84e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.34e-06	3.82e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—breast cancer	1.34e-06	3.82e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACHE—breast cancer	1.33e-06	3.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—breast cancer	1.33e-06	3.79e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—breast cancer	1.31e-06	3.75e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA1—breast cancer	1.31e-06	3.73e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—breast cancer	1.3e-06	3.71e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ERCC2—breast cancer	1.29e-06	3.68e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP19A1—breast cancer	1.29e-06	3.68e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—STK11—breast cancer	1.29e-06	3.68e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—breast cancer	1.27e-06	3.64e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—breast cancer	1.27e-06	3.62e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAF1—breast cancer	1.26e-06	3.61e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RELA—breast cancer	1.26e-06	3.59e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP17A1—breast cancer	1.26e-06	3.59e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—breast cancer	1.25e-06	3.57e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO1—breast cancer	1.24e-06	3.55e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS1—breast cancer	1.24e-06	3.55e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—breast cancer	1.23e-06	3.52e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—breast cancer	1.23e-06	3.52e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2D6—breast cancer	1.22e-06	3.48e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—breast cancer	1.21e-06	3.46e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.21e-06	3.45e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—COMT—breast cancer	1.2e-06	3.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA2—breast cancer	1.2e-06	3.42e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—breast cancer	1.19e-06	3.4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—breast cancer	1.18e-06	3.39e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—breast cancer	1.17e-06	3.36e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ITPR1—breast cancer	1.17e-06	3.35e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FASN—breast cancer	1.16e-06	3.32e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—breast cancer	1.16e-06	3.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—breast cancer	1.16e-06	3.3e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A5—breast cancer	1.14e-06	3.26e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—breast cancer	1.13e-06	3.24e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—breast cancer	1.13e-06	3.24e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—breast cancer	1.13e-06	3.22e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—breast cancer	1.12e-06	3.2e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—breast cancer	1.12e-06	3.19e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMS—breast cancer	1.11e-06	3.16e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—breast cancer	1.11e-06	3.16e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—breast cancer	1.1e-06	3.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A1—breast cancer	1.1e-06	3.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NQO1—breast cancer	1.1e-06	3.15e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUN—breast cancer	1.1e-06	3.15e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.09e-06	3.13e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOR1—breast cancer	1.09e-06	3.13e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—breast cancer	1.09e-06	3.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—breast cancer	1.09e-06	3.12e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—breast cancer	1.07e-06	3.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—breast cancer	1.07e-06	3.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—breast cancer	1.07e-06	3.04e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—breast cancer	1.06e-06	3.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1B1—breast cancer	1.06e-06	3.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—breast cancer	1.05e-06	3e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—breast cancer	1.04e-06	2.98e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—breast cancer	1.04e-06	2.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.04e-06	2.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ERCC2—breast cancer	1.03e-06	2.94e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—breast cancer	1.02e-06	2.91e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA1—breast cancer	1.01e-06	2.88e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STK11—breast cancer	9.93e-07	2.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP19A1—breast cancer	9.93e-07	2.84e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—breast cancer	9.88e-07	2.82e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—breast cancer	9.77e-07	2.79e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—breast cancer	9.68e-07	2.77e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—breast cancer	9.67e-07	2.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—breast cancer	9.62e-07	2.75e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—breast cancer	9.53e-07	2.72e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—breast cancer	9.44e-07	2.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—COMT—breast cancer	9.23e-07	2.64e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—breast cancer	9.19e-07	2.63e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—breast cancer	9.1e-07	2.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—breast cancer	9.06e-07	2.59e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ITPR1—breast cancer	9.04e-07	2.59e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—breast cancer	8.95e-07	2.56e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—breast cancer	8.92e-07	2.55e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—breast cancer	8.85e-07	2.53e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—breast cancer	8.83e-07	2.53e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—breast cancer	8.83e-07	2.52e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—breast cancer	8.7e-07	2.49e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—breast cancer	8.66e-07	2.47e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMS—breast cancer	8.54e-07	2.44e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.52e-07	2.44e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—breast cancer	8.45e-07	2.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOR1—breast cancer	8.45e-07	2.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—breast cancer	8.45e-07	2.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.45e-07	2.41e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—breast cancer	8.44e-07	2.41e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—breast cancer	8.18e-07	2.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—breast cancer	8.13e-07	2.32e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—breast cancer	8.09e-07	2.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—breast cancer	8.01e-07	2.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ERCC2—breast cancer	7.94e-07	2.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—breast cancer	7.8e-07	2.23e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—breast cancer	7.73e-07	2.21e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—breast cancer	7.51e-07	2.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—breast cancer	7.46e-07	2.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—breast cancer	7.27e-07	2.08e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—breast cancer	7.14e-07	2.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—breast cancer	7.05e-07	2.02e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—breast cancer	6.95e-07	1.99e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—breast cancer	6.89e-07	1.97e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—breast cancer	6.75e-07	1.93e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—breast cancer	6.74e-07	1.93e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—breast cancer	6.65e-07	1.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—breast cancer	6.27e-07	1.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—breast cancer	6.23e-07	1.78e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—breast cancer	6.17e-07	1.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—breast cancer	6.14e-07	1.75e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—breast cancer	5.95e-07	1.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—breast cancer	5.51e-07	1.58e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—breast cancer	5.44e-07	1.56e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—breast cancer	5.38e-07	1.54e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—breast cancer	5.21e-07	1.49e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—breast cancer	4.86e-07	1.39e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—breast cancer	4.81e-07	1.37e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—breast cancer	4.76e-07	1.36e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—breast cancer	4.75e-07	1.36e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—breast cancer	4.15e-07	1.19e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—breast cancer	3.88e-07	1.11e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—breast cancer	3.8e-07	1.08e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—breast cancer	3.1e-07	8.86e-06	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—breast cancer	2.93e-07	8.37e-06	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—breast cancer	2.39e-07	6.84e-06	CbGpPWpGaD
